Friday, 16 October 2026European Markets

ALAN ALLMAN Stock Was Up By 10% On Tuesday

Loading stream...

(vianews) - the market ended the session with alan allman (aaa.pa) jumping 10% to €6.60 on tuesday while cac 40 slid 0.93% to €7,575.10.

alan allman's last close was €6.00, 54.2% below its 52-week high of €13.10.

about alan allman

alan allman associates, together with its subsidiaries, engages in the provision of consulting services in canada, france, belgium, luxembourg, switzerland, and singapore. the company offers technology consulting in the areas, including cybersecurity, cloud, data management, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, commercial intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, process consulting, etc. the company was incorporated in 1954 and is based in issy-les-moulineaux, france.

earnings per share

as for profitability, alan allman has a trailing twelve months eps of €0.13.

pe ratio

alan allman has a trailing twelve months price to earnings ratio of 50.77. meaning, the purchaser of the share is investing €50.77 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.5%.

volatility

alan allman's last week, last month's, and last quarter's current intraday variation average was a negative 1.24%, a negative 2.13%, and a positive 2.56%.

alan allman's highest amplitude of average volatility was 2.97% (last week), 2.76% (last month), and 2.56% (last quarter).

yearly top and bottom value

alan allman's stock is valued at €6.60 at 22:30 est, way below its 52-week low of €8.44.

moving average

alan allman's value is way below its 50-day moving average of €9.88 and way under its 200-day moving average of €10.73.

volume

today's last reported volume for alan allman is 2178 which is 423.55% above its average volume of 416.

more news about alan allman (aaa.pa).

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com